AAAAAA

   
Results: 1-25 | 26-46 |
Results: 26-46/46
Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants
Authors: Kulkarni, S Powles, R Treleaven, J Riley, U Singhal, S Horton, C Sirohi, B Bhagwati, N Meller, S Saso, R Mehta, J
Citation: S. Kulkarni et al., Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants, BLOOD, 95(12), 2000, pp. 3683-3686
Stem cell transplantation for multiple myeloma - 10 years later
Authors: Siegel, DS Lim, SH Tricot, G Desikan, KR Fassas, A Mehta, J Singhal, S Anaissie, E Jagannath, S Barlogie, B
Citation: Ds. Siegel et al., Stem cell transplantation for multiple myeloma - 10 years later, HEMATOPOIETIC STEM CELL TRANSPLANTION, 2000, pp. 499-516
Use of antioxidants in cardiovascular medicine
Authors: Mehta, JL Li, DY Mehta, J
Citation: Jl. Mehta et al., Use of antioxidants in cardiovascular medicine, DEV CARD M, 233, 2000, pp. 225-238
The graft-versus-myeloma effect
Authors: Mehta, J
Citation: J. Mehta, The graft-versus-myeloma effect, BAS CLIN ON, 22, 2000, pp. 223-238
The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy
Authors: Mehta, J Powles, R Treleaven, J Swansbury, GJ Kulkarni, S Saso, R Min, T Singhal, S
Citation: J. Mehta et al., The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy, LEUK LYMPH, 34(5-6), 1999, pp. 553-560
Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling
Authors: Singhal, S Powles, R Treleaven, J Kulkarni, S Horton, C Mehta, J
Citation: S. Singhal et al., Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling, LEUK LYMPH, 34(3-4), 1999, pp. 287-294
Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse
Authors: Singhal, S Powles, R Kulkarni, S Treleaven, J Saso, R Mehta, J
Citation: S. Singhal et al., Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse, LEUK LYMPH, 32(5-6), 1999, pp. 505-512
Business excellence through quality: Indian experience
Authors: Mehta, J
Citation: J. Mehta, Business excellence through quality: Indian experience, TOT QUAL M, 10(4-5), 1999, pp. S647-S652
Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy
Authors: Aslan, T Fassas, AT Desikan, R Siegel, D Munshi, NC Mehta, J Singhal, S Barlogie, B Anaissie, E
Citation: T. Aslan et al., Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy, BONE MAR TR, 24(5), 1999, pp. 505-509
Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy
Authors: Singhal, S Mehta, J Desikan, K Siegel, D Singh, J Munshi, N Spoon, D Anaissie, E Ayers, D Barlogie, B
Citation: S. Singhal et al., Collection of peripheral blood stem cells after a preceding autograft: unfavorable effect of prior interferon-alpha therapy, BONE MAR TR, 24(1), 1999, pp. 13-17
Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation
Authors: Singhal, S Powles, R Treleaven, J Kulkarni, S Horton, C Mehta, J
Citation: S. Singhal et al., Long-term outcome of adult acute leukemia patients who are alive and well 2 years after autologous blood or marrow transplantation, BONE MAR TR, 23(9), 1999, pp. 875-879
Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)
Authors: Kulkarni, S Rodriguez, M Lafuente, A Mateos, P Mehta, J Singhal, S Saso, R Dait, D Treleaven, JG Powles, RL
Citation: S. Kulkarni et al., Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD), BONE MAR TR, 23(8), 1999, pp. 803-807
Reimmunization after blood or marrow stem cell transplantation
Authors: Singhal, S Mehta, J
Citation: S. Singhal et J. Mehta, Reimmunization after blood or marrow stem cell transplantation, BONE MAR TR, 23(7), 1999, pp. 637-646
Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
Authors: Kulkarni, S Powles, RL Treleaven, JG Singhal, S Saso, R Horton, C Killick, S Tait, D Ramiah, V Mehta, J
Citation: S. Kulkarni et al., Impact of previous high-dose therapy on outcome after allografting for multiple myeloma, BONE MAR TR, 23(7), 1999, pp. 675-680
Antitumor activity of thalidomide in refractory multiple myeloma.
Authors: Singhal, S Mehta, J Desikan, R Ayers, D Roberson, P Eddlemon, P Munshi, N Anaissie, E Wilson, C Dhodapkar, M Zeldis, J Barlogie, B Siegel, D Crowley, J
Citation: S. Singhal et al., Antitumor activity of thalidomide in refractory multiple myeloma., N ENG J MED, 341(21), 1999, pp. 1565-1571
Vitamins C and E prolong time to arterial thrombosis in rats
Authors: Mehta, J Li, DY Mehta, JL
Citation: J. Mehta et al., Vitamins C and E prolong time to arterial thrombosis in rats, J NUTR, 129(1), 1999, pp. 109-112
Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed diseaseentity with a new staging system
Authors: Sirohi, B Powles, R Mehta, J Raje, N Kulkarni, S Ramiah, V Saso, R Horton, C Bhagwati, N Singhal, S Treleaven, J
Citation: B. Sirohi et al., Complete remission rate and outcome after intensive treatment of 177 patients under 75 years of age with IgG myeloma defining a circumscribed diseaseentity with a new staging system, BR J HAEM, 107(3), 1999, pp. 656-666
High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia
Authors: Desikan, R Dhodapkar, M Siegel, D Fassas, A Singh, J Singhal, S Mehta, J Vesole, D Tricot, G Jagannath, S Anaissie, E Barlogie, B Munshi, NC
Citation: R. Desikan et al., High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia, BR J HAEM, 105(4), 1999, pp. 993-996
Lipid preparations of amphotericin for the treatment of fungal infections
Authors: Mehta, J
Citation: J. Mehta, Lipid preparations of amphotericin for the treatment of fungal infections, BR J HAEM, 105(3), 1999, pp. 845-847
Age is not a prognostic variable with autotransplants for multiple myeloma
Authors: Siegel, DS Desikan, KR Mehta, J Singhal, S Fassas, A Munshi, N Anaissie, E Naucke, S Ayers, D Spoon, D Vesole, D Tricot, G Barlogie, B
Citation: Ds. Siegel et al., Age is not a prognostic variable with autotransplants for multiple myeloma, BLOOD, 93(1), 1999, pp. 51-54
Total therapy with tandem transplants for newly diagnosed multiple myeloma
Authors: Barlogie, B Jagannath, S Desikan, KR Mattox, S Vesole, D Siegel, D Tricot, G Munshi, N Fassas, A Singhal, S Mehta, J Anaissie, E Dhodapkar, D Naucke, S Cromer, J Sawyer, J Epstein, J Spoon, D Ayers, D Cheson, B Crowley, J
Citation: B. Barlogie et al., Total therapy with tandem transplants for newly diagnosed multiple myeloma, BLOOD, 93(1), 1999, pp. 55-65
Risultati: 1-25 | 26-46 |